Bioasis has brought together a team of exceptional leaders from the biopharmaceutical industry. Their experience in collaborative research, drug development, alliances and commercialization provides the vision and expertise to enable Bioasis to revolutionize the treatment of neurological diseases.
Leadership Team
-
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE
Executive Chair
-
Dave Jenkins
Chief Financial Officer
-
Mei Mei Tian, Ph.D.
Vice President, Head of External Research
-
Prof. Francois Curtin
Medical Advisor
-
Prof Alois B. Lang
CMC consultant
-
Prof. Ferdinando Nicoletti
Preclinical Consultant
-
John Proffett
Business Development Advisor
-
Jeffrey Sprouse, Ph.D.
Preclinical Program Manager
-
Graeme Dick
Director, Investor Relations
-
Doris Westhoff, Ph.D.
Project Manager